Cano Health (CANO) reported Q2 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $689.4 million versus the consensus estimate of $712.61 million.
GUIDANCE:
Cano Health sees FY2022 revenue of $2.85-2.9 billion, versus the consensus of $2.86 billion.